Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Alpine Immune Sciences, Inc. Common Stock (ALPN)

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $XXX Billion, following positive clinical trial data for Povetacicept and significant insider transactions.

### About Alpine Immune Sciences, Inc. Common Stock
Alpine Immune Sciences, Inc. is a healthcare company focused on immunology, trading under the ticker ALPN.  
Alpine Immune Sciences, Inc. Common Stock uses the ticker $ALPN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Alpine Immune Sciences, Inc. Common Stock (ALPN) market dominance near a 52-week low at XXXXXXX.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) creators hit XX which is XXX% higher than it's daily average.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) social dominance is up 1150% from the previous X months.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) creators is up XXXXXX% from the previous week.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) mentions is up XXXXXX% from the previous week.

### Price: $XX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/close.tsv)  
The stock price has reached a 1-year high, driven by positive clinical trial data for Povetacicept and insider transactions, indicating strong investor confidence. This is occurring despite ALPN's market dominance being near a 52-week low, suggesting that social sentiment and specific company news are currently outweighing broader market share metrics.  

1-Year High: $XX on 2024-12-11  
1-Year Low: $XX on 2024-12-11  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/alt_rank.tsv)  
Alpine Immune Sciences, Inc. Common Stock (ALPN) is currently AltRank #1,196 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXXXX +121  
X Month: XXXXX +508  
X Months: XXXXX +190  
X Year: XXXXX +141  
1-Year High: XXXXX on 2025-08-23  
1-Year Low: XX on 2025-01-05  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +2  
X Month: XX -XX  
X Months: XX +11  
X Year: XX -XX  
1-Year High: XX on 2025-03-03  
1-Year Low: XX on 2025-06-05  
  
  
### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXXXX +8.80%  
X Month: XXXXXX +56%  
X Months: XXXXXX -XX%  
X Year: XXXXXXX -XX%  
1-Year High: XXXXXX on 2024-12-23  
1-Year Low: XX on 2025-09-15  

Engagements by network (24h):
Reddit: XX
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX +343%  
X Month: XX +58%  
X Months: XXX -XX%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2025-01-23  
1-Year Low: X on 2025-09-06  

Mentions by network (24h):
Reddit: XX
X: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Alpine Immune Sciences, Inc. Common Stock (ALPN) in the last XX hours which is up XXX% from X in the previous XX hours
Daily Average: X  
X Week: XX +533%  
X Month: XX +163%  
X Months: XXX -XX%  
X Year: XXX -XX%  
1-Year High: XX on 2025-01-23  
1-Year Low: X on 2025-07-06  

The most influential creators that mention Alpine Immune Sciences, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@insiderscreener](/creator/twitter/insiderscreener) | X    | XXXXX     | X     | XXX         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$alpn/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Month: XX% -XX%  
X Months: XX% +56%  
X Year: XX% +39%  
1-Year High: XXX% on 2025-06-19  
1-Year Low: XX% on 2024-12-16  

Most Supportive Themes:
- Clinical Trial Data: (40%) Positive clinical trial data for Povetacicept has been a significant driver for ALPN.
- Insider Transactions: (30%) Insider transactions have been reported, indicating strong investor confidence in ALPN.
- Partnerships and Acquisitions: (30%) Partnerships, such as with Evotec, and acquisitions, like Vertex's interest, are boosting ALPN's profile.
  
Most Critical Themes:
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXXXX%  
X Week: XXXXXX% +0.00129%  
X Month: XXXXXX% +0.0068%  
X Months: XXXXXX% +0.0048%  
X Year: XXXXXX% +0.0038%  
1-Year High: XXXXX% on 2025-01-02  
1-Year Low: XXXXXX% on 2025-09-20  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXXXX% on 2025-04-08  
1-Year Low: XXXXXXX% on 2025-10-28  

### Top Alpine Immune Sciences, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$ALPN Awaiting Buy Signal based off X signals $1768 net profit XXXXX profit factor XX% win rate on a 15-min chart. #investing #daytrading 🚀 Free trial at UltraAlgo.com"  
[Reddit Link](https://redd.it/yxv44j) [@PatternTrader2](/creator/reddit/PatternTrader2) 2025-12-09T18:49Z X followers, X engagements


"$ALPN - Alpine Immune Doses First Patient in Mid-Stage Study of Lupus Drug Candidate; Receives $XX Million Milestone Payment"  
[Reddit Link](https://redd.it/o70cn8) [@TeamofStockTraders](/creator/reddit/TeamofStockTraders) 2025-12-09T18:49Z X followers, X engagements


"$ALPN Trading Signals Awaiting Buy Signal based off XX signals $2614 net profit XXXX profit factor XX% win rate. âš¡ See more with a Free Trial at UltraAlgo.com/Videos"  
[Reddit Link](https://redd.it/yk6wwv) [@PatternTrader2](/creator/reddit/PatternTrader2) 2025-12-09T18:49Z X followers, X engagements


"$ALPN Day Trading Awaiting Short Signal based off XX signals on the 15-min chart. Find more Stock Trading Ideas at UltraAlgo.com"  
[Reddit Link](https://redd.it/y6gfz9) [@PatternTrader2](/creator/reddit/PatternTrader2) 2025-12-09T18:49Z X followers, X engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Alpine Immune Sciences, Inc. Common Stock (ALPN)

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $XXX Billion, following positive clinical trial data for Povetacicept and significant insider transactions.

About Alpine Immune Sciences, Inc. Common Stock

Alpine Immune Sciences, Inc. is a healthcare company focused on immunology, trading under the ticker ALPN.
Alpine Immune Sciences, Inc. Common Stock uses the ticker $ALPN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Alpine Immune Sciences, Inc. Common Stock (ALPN) market dominance near a 52-week low at XXXXXXX.
  • Alpine Immune Sciences, Inc. Common Stock (ALPN) creators hit XX which is XXX% higher than it's daily average.
  • Alpine Immune Sciences, Inc. Common Stock (ALPN) social dominance hit XXXXXX which is XXX% higher than it's daily average.
  • Alpine Immune Sciences, Inc. Common Stock (ALPN) social dominance is up 1150% from the previous X months.
  • Alpine Immune Sciences, Inc. Common Stock (ALPN) creators is up XXXXXX% from the previous week.
  • Alpine Immune Sciences, Inc. Common Stock (ALPN) mentions is up XXXXXX% from the previous week.

Price: $XX

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has reached a 1-year high, driven by positive clinical trial data for Povetacicept and insider transactions, indicating strong investor confidence. This is occurring despite ALPN's market dominance being near a 52-week low, suggesting that social sentiment and specific company news are currently outweighing broader market share metrics.

1-Year High: $XX on 2024-12-11
1-Year Low: $XX on 2024-12-11

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Alpine Immune Sciences, Inc. Common Stock (ALPN) is currently AltRank #1,196 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX +121
X Month: XXXXX +508
X Months: XXXXX +190
X Year: XXXXX +141
1-Year High: XXXXX on 2025-08-23
1-Year Low: XX on 2025-01-05

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +2
X Month: XX -XX
X Months: XX +11
X Year: XX -XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-06-05

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXXXX +8.80%
X Month: XXXXXX +56%
X Months: XXXXXX -XX%
X Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2024-12-23
1-Year Low: XX on 2025-09-15

Engagements by network (24h): Reddit: XX X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX +343%
X Month: XX +58%
X Months: XXX -XX%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-01-23
1-Year Low: X on 2025-09-06

Mentions by network (24h): Reddit: XX X: XX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Alpine Immune Sciences, Inc. Common Stock (ALPN) in the last XX hours which is up XXX% from X in the previous XX hours Daily Average: X
X Week: XX +533%
X Month: XX +163%
X Months: XXX -XX%
X Year: XXX -XX%
1-Year High: XX on 2025-01-23
1-Year Low: X on 2025-07-06

The most influential creators that mention Alpine Immune Sciences, Inc. Common Stock in the last XX hours

Creator Rank Followers Posts Engagements
@insiderscreener X XXXXX X XXX
@doepke_michel X XXXXX X XX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Month: XX% -XX%
X Months: XX% +56%
X Year: XX% +39%
1-Year High: XXX% on 2025-06-19
1-Year Low: XX% on 2024-12-16

Most Supportive Themes:

  • Clinical Trial Data: (40%) Positive clinical trial data for Povetacicept has been a significant driver for ALPN.
  • Insider Transactions: (30%) Insider transactions have been reported, indicating strong investor confidence in ALPN.
  • Partnerships and Acquisitions: (30%) Partnerships, such as with Evotec, and acquisitions, like Vertex's interest, are boosting ALPN's profile.

Most Critical Themes:

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% +0.00129%
X Month: XXXXXX% +0.0068%
X Months: XXXXXX% +0.0048%
X Year: XXXXXX% +0.0038%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-09-20

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-04-08
1-Year Low: XXXXXXX% on 2025-10-28

Top Alpine Immune Sciences, Inc. Common Stock Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$ALPN Awaiting Buy Signal based off X signals $1768 net profit XXXXX profit factor XX% win rate on a 15-min chart. #investing #daytrading 🚀 Free trial at UltraAlgo.com"
Reddit Link @PatternTrader2 2025-12-09T18:49Z X followers, X engagements

"$ALPN - Alpine Immune Doses First Patient in Mid-Stage Study of Lupus Drug Candidate; Receives $XX Million Milestone Payment"
Reddit Link @TeamofStockTraders 2025-12-09T18:49Z X followers, X engagements

"$ALPN Trading Signals Awaiting Buy Signal based off XX signals $2614 net profit XXXX profit factor XX% win rate. âš¡ See more with a Free Trial at UltraAlgo.com/Videos"
Reddit Link @PatternTrader2 2025-12-09T18:49Z X followers, X engagements

"$ALPN Day Trading Awaiting Short Signal based off XX signals on the 15-min chart. Find more Stock Trading Ideas at UltraAlgo.com"
Reddit Link @PatternTrader2 2025-12-09T18:49Z X followers, X engagements

Alpine Immune Sciences, Inc. Common Stock (ALPN)
/topic/$alpn